NASDAQ: CDXSCodexis Inc Stock Ownership - Who owns Codexis?
Insider buying vs selling
Have Codexis Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Vre Raymond De | Director | 2026-06-11 | 2,605 | $2.37 | $6.17kSell |
| Stefan Lutz | Chief Scientific Officer | 2026-02-24 | 5,862 | $1.13 | $6.64kSell |
| Stefan Lutz | Chief Scientific Officer | 2026-02-06 | 2,492 | $1.31 | $3.26kSell |
| Alison Moore | President and CEO | 2026-02-06 | 3,826 | $1.31 | $5.00kSell |
| Georgia Erbez | Chief Financial Officer and Chief Business Officer | 2026-02-06 | 3,826 | $1.31 | $5.00kSell |
| Stefan Lutz | CSO | 2026-01-07 | 4,685 | $1.70 | $7.95kSell |
| Opaleye Management Inc | 10% Owner | 2025-12-01 | 245,000 | $1.67 | $408.42kSell |
| Opaleye Management Inc | 10% Owner | 2025-12-01 | 245,000 | $1.67 | $408.42kSell |
| Opaleye Management Inc | 10% Owner | 2025-12-01 | 8,533 | $1.67 | $14.22kSell |
| Opaleye Management Inc | 10% Owner | 2025-12-01 | 8,533 | $1.67 | $14.22kSell |
CDXS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CDXS insiders and whales buy or sell their stock.
CDXS Shareholders
What type of owners hold Codexis Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vivo Ventures VII LLC | 17.78% | 16,159,248 | $41.53M | Insider |
| Equilon Enterprises LLC | 12.26% | 11,146,638 | $28.65M | Insider |
| Opaleye Management Inc | 11.15% | 10,134,989 | $26.05M | Insider |
| Aberdeen Group PLC | 9.55% | 8,680,368 | $22.31M | Institution |
| Blackrock Inc | 7.73% | 7,028,773 | $18.06M | Institution |
| Opaleye Management Inc | 7.46% | 6,785,000 | $17.44M | Institution |
| James R. Sulat | 6.55% | 5,957,108 | $15.31M | Insider |
| Brazil Holding Bv Shell | 6.13% | 5,573,319 | $14.32M | Insider |
| Participacoes Ltda Ispagnac | 6.13% | 5,573,319 | $14.32M | Insider |
| Energia Participacoes Sa Raizen | 6.13% | 5,573,319 | $14.32M | Insider |
CDXS vs Biotech Stocks
Codexis Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.